…
Selectis Health, Inc. is a healthcare owner-operator that acquires, develops, and manages skilled nursing facilities, assisted living facilities, and independent living facilities across the South and Southeastern United States. The Company currently operates eight properties in Arkansas and Oklahoma, providing post-acute and skilled nursing care, assisted and independent living services, and continuing care retirement programs, with reimbursement sourced through Medicare, Medicaid, and private pay arrangements. Selectis is focused on delivering quality resident care while pursuing strategic growth opportunities in an expanding senior healthcare market. Selectis Health, Inc. was established and incorporated on June 08, 1978, in Utah. As of September 1, 2026, Selectis Health, Inc. operates as a subsidiary of Black Pearl Equities, LLC, Investment Arm.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Global Healthcare REIT Inc (GBCS on the Pink Sheets) is a publicly quoted company that, based on name and sparse filings, appears to invest in healthcare real estate. Long-term drivers may include demographic aging and steady demand for clinical and senior-care properties, which could support rental income and make the company appealing for sector exposure and potential yield.
Main risks are low trading liquidity as a Pink-listed issuer, concentrated tenant and financing vulnerabilities and regulatory/reimbursement exposure common to small healthcare landlords.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | -1.01M | -2.42M | -3.97M | -2.24M | -2.24M |
| Minority interest | - | - | 0.00M | 0.00M | -0.01M |
| Net income | -1.02M | -2.42M | -3.97M | -5.38M | -2.25M |
| Selling general administrative | 8.89M | 9.25M | 9.97M | 5.91M | 5.91M |
| Selling and marketing expenses | - | 1.04M | 2.73M | - | - |
| Gross profit | 6.73M | 9.13M | 5.41M | 6.30M | 6.30M |
| Reconciled depreciation | 1.47M | 1.57M | 1.67M | 1.79M | 1.73M |
| Ebit | 0.71M | -0.38M | -8.96M | -0.09M | -0.73M |
| Ebitda | 2.19M | 1.19M | -7.29M | 1.64M | 1.99M |
| Depreciation and amortization | 1.47M | 1.57M | 1.67M | 1.73M | - |
| Operating income | -1.56M | -2.73M | -8.96M | -0.09M | -0.73M |
| Other operating expenses | 43.01M | 42.22M | 45.74M | 28.50M | - |
| Interest expense | 1.73M | 2.05M | 2.17M | 2.50M | 2.50M |
| Tax provision | 0.00M | 0.00M | - | - | - |
| Net interest income | -1.73M | -2.05M | -2.17M | -2.23M | -2.50M |
| Income tax expense | 0.00M | -0.02M | -8.96M | 3.14M | - |
| Total revenue | 41.44M | 39.49M | 36.78M | 27.77M | 27.77M |
| Total operating expenses | 8.30M | 11.86M | 12.76M | 7.03M | 28.50M |
| Cost of revenue | 34.71M | 30.36M | 31.38M | 21.47M | 21.47M |
| Total other income expense net | 0.55M | 0.31M | 4.99M | -2.15M | 0.99M |
| Net income from continuing ops | -1.02M | -2.42M | -3.97M | -2.40M | -2.24M |
| Net income applicable to common shares | - | - | - | - | -2.28M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 32.58M | 33.45M | 40.67M | 46.92M | 46.92M |
| Other current assets | 4.17M | 0.23M | -3.58M | 0.50M | 0.50M |
| Total liab | 38.79M | 38.86M | 43.64M | 43.82M | 43.82M |
| Total stockholder equity | -6.21M | -5.41M | -2.96M | 3.10M | 3.10M |
| Other current liab | 6.95M | 0.05M | 6.08M | 0.93M | 0.94M |
| Common stock | 0.15M | 0.15M | 0.15M | 0.15M | 0.15M |
| Capital stock | 0.93M | 0.93M | 0.93M | 0.93M | 0.93M |
| Retained earnings | -21.24M | -20.19M | -17.75M | -11.32M | -11.32M |
| Other liab | - | - | - | - | 0.23M |
| Good will | 1.08M | 1.08M | 1.08M | 1.08M | 1.08M |
| Other assets | - | - | - | - | 0.85M |
| Cash | 1.01M | 0.68M | 1.48M | 3.94M | 3.94M |
| Total current liabilities | 25.27M | 19.63M | 18.15M | 11.79M | 11.79M |
| Current deferred revenue | - | - | -6.05M | 0.01M | - |
| Net debt | 24.43M | 31.55M | 35.76M | 34.56M | 34.33M |
| Short term debt | 12.04M | 13.00M | 12.07M | 6.46M | - |
| Short long term debt | 12.04M | 13.00M | 12.07M | 3.20M | 6.46M |
| Short long term debt total | 25.45M | 32.23M | 37.25M | 38.50M | - |
| Other stockholder equity | 14.10M | 14.25M | 14.23M | 13.49M | - |
| Property plant equipment | - | - | - | - | 37.02M |
| Total current assets | 7.58M | 3.53M | 4.96M | 7.97M | 7.94M |
| Net tangible assets | - | - | - | - | 1.25M |
| Short term investments | - | - | - | 0.02M | 0.02M |
| Net receivables | 2.40M | 2.62M | 2.09M | 3.51M | 3.51M |
| Long term debt | 13.41M | 19.13M | 25.18M | 34.40M | 31.80M |
| Accounts payable | 6.29M | 6.57M | 6.05M | 4.39M | 4.39M |
| Accumulated other comprehensive income | - | - | -0.38M | -0.38M | - |
| Non currrent assets other | 0.84M | 0.71M | 1.38M | 0.85M | 0.85M |
| Non current assets total | 25.00M | 29.92M | 35.71M | 38.96M | 38.96M |
| Capital lease obligations | 0.11M | 0.10M | 0.31M | 0.29M | 0.23M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | - | 2.45M | -0.03M | -0.22M | -0.52M |
| Change to liabilities | - | - | - | - | 2.11M |
| Total cashflows from investing activities | -0.44M | - | - | - | -0.52M |
| Net borrowings | -0.98M | - | - | - | 1.02M |
| Total cash from financing activities | -0.98M | -1.54M | -0.62M | 1.61M | 1.61M |
| Change to operating activities | - | - | - | - | 0.67M |
| Net income | -1.02M | -2.42M | -3.97M | -2.24M | -2.25M |
| Change in cash | 0.46M | -0.91M | 0.06M | 0.81M | 0.81M |
| Begin period cash flow | 1.39M | 2.30M | 1.42M | 3.98M | 3.98M |
| End period cash flow | 1.85M | 1.39M | 1.48M | 4.79M | 4.79M |
| Total cash from operating activities | 1.88M | -1.82M | 0.54M | -0.27M | -0.27M |
| Issuance of capital stock | - | - | - | 0.00M | 0.71M |
| Depreciation | 1.47M | 1.57M | 1.67M | 1.73M | 1.73M |
| Other cashflows from investing activities | - | 2.48M | - | 0.06M | - |
| Dividends paid | 0.00M | 0.02M | 0.01M | 0.03M | 0.03M |
| Change to account receivables | -0.54M | -1.57M | -0.66M | -2.47M | -2.47M |
| Sale purchase of stock | - | - | - | 9.13M | 0.00M |
| Other cashflows from financing activities | -0.98M | -1.51M | 0.08M | -0.09M | -0.09M |
| Change to netincome | - | - | - | - | -0.22M |
| Capital expenditures | 0.44M | 0.04M | 0.03M | 0.52M | 0.52M |
| Change in working capital | 0.44M | -0.00M | -0.24M | 0.31M | 0.31M |
| Stock based compensation | - | 0.00M | 0.00M | 0.02M | 0.02M |
| Other non cash items | 0.98M | -0.97M | 4.67M | 0.16M | 0.16M |
| Free cash flow | 1.44M | -1.86M | 0.51M | -0.79M | -0.79M |
Sector: Healthcare Industry: Medical Care Facilities
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| HCA HCA Healthcare, Inc. |
1.17 0.23% |
507.21 | 14.27 | 13.46 | 1.21 | 291.34 | 1.83 | 8.99 |
| THC Tenet Healthcare Corporation |
-1.82 0.62% |
291.15 | 10.08 | 12.66 | 0.96 | 4.57 | 1.43 | 5.80 |
| FSNUY Fresenius SE & Co KGaA ADR |
0.12 0.84% |
14.84 | 16.87 | 9.44 | 0.42 | 0.78 | 0.79 | 5.37 |
| JDHIY JD Health International Inc |
- -% |
5.57 | 62.50 | 35.97 | 0.30 | 2.32 | 0.16 | 3.90 |
Selectis Health, Inc. is a healthcare owner-operator that acquires, develops, and manages skilled nursing facilities, assisted living facilities, and independent living facilities across the South and Southeastern United States. The Company currently operates eight properties in Arkansas and Oklahoma, providing post-acute and skilled nursing care, assisted and independent living services, and continuing care retirement programs, with reimbursement sourced through Medicare, Medicaid, and private pay arrangements. Selectis is focused on delivering quality resident care while pursuing strategic growth opportunities in an expanding senior healthcare market. Selectis Health, Inc. was established and incorporated on June 08, 1978, in Utah. As of September 1, 2026, Selectis Health, Inc. operates as a subsidiary of Black Pearl Equities, LLC, Investment Arm.
| Name | Title | Year Born |
|---|---|---|
| Mr. Lance Jason Baller | Chairman & CEO | 1973 |
| Mr. Christopher R. Barker | Pres, COO & Director | 1968 |
| Ms. Christine Lucus | CFO & Company Sec. | 1990 |
| Ms. Sarah Day | Director of Therapy, Marketing & Staffing | NA |
| Mr. Adam Desmond | CEO, Interim CFO & Director | 1971 |
| Ms. Sarah Day | Vice President of Operations | NA |
| Mr. Clifford L. Neuman | Director & Legal Counsel | 1948 |
| Ms. Christine Lucus | Company Secretary | 1990 |
| Ms. Jamie Trost | Vice President of Human Resources | NA |
| Ms. Heidi Kramer | Chief of Staff | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.